SLP

Simulations Plus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

50.67
+2.24
+4.63%
Closed 17:02 05/29 EDT
OPEN
48.22
PREV CLOSE
48.43
HIGH
52.73
LOW
47.31
VOLUME
3.17M
TURNOVER
--
52 WEEK HIGH
52.73
52 WEEK LOW
24.08
MARKET CAP
900.31M
P/E (TTM)
100.82
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SLP stock price target is 42.25 with a high estimate of 44.50 and a low estimate of 40.00.

EPS

SLP News

More
Stocks That Hit 52-Week Highs On Friday
On Friday morning, 45 companies hit new 52-week highs.
Benzinga · 2d ago
65 Biggest Movers From Yesterday
Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) shares climbed 386.3% to close at $19.21 on Thursday after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.
Benzinga · 3d ago
Why Diversified Healthcare Trust, Simulation Plus, and Hudson Pacific Properties Are Rising Today
MotleyFool.com · 3d ago
48 Stocks Moving In Thursday's Mid-Day Session
Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) shares jumped 207.6% to $12.15 after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.
Benzinga · 3d ago
Stocks That Hit 52-Week Highs On Thursday
During Thursday's morning trading, 73 companies set new 52-week highs.
Benzinga · 3d ago
Simulations Plus Receives New Grant Award from the FDA
Business Wire · 3d ago
Simulations Plus Receives New Grant Award From FDA For Ophthalmic Drug
Novel PBPK/PD modeling strategies for ophthalmic drug products will inform regulatory decision-making Simulations Plus, Inc. (NASDAQ:SLP), the leading provider of modeling and simulation solutions for the
Benzinga · 3d ago
Hudson Pacific Properties Set to Join S&P MidCap 400; Diversified Healthcare Trust, Palomar Holdings & Simulations Plus to Join S&P SmallCap 600
PR Newswire · 4d ago

Industry

Advanced Medical Equipment & Technology
+1.42%
Healthcare Equipment & Supplies
+1.33%

Hot Stocks

Symbol
Price
%Change

About SLP

Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.
More

Webull offers kinds of Simulations Plus, Inc. stock information, including NASDAQ:SLP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLP stock news, and many more online research tools to help you make informed decisions.